Filter
574
Filtered Results: 574
Text search:
microbiological
risk
assessment
Featured
Recommendations
77
New Publications
159
Language
Document type
No document type
299
Guidelines
118
Studies & Reports
82
Manuals
44
Strategic & Response Plan
19
Situation Updates
6
Training Material
3
Fact sheets
2
Brochures
1
Countries / Regions
India
54
Western and Central Europe
19
Ethiopia
15
Global
13
Kenya
12
Latin America and the Carribbean
12
South Africa
11
Tanzania
10
Bangladesh
10
Nigeria
9
Uganda
8
Eastern Europe
8
Sierra Leone
7
Africa
7
Nepal
6
Ghana
6
Malawi
6
Eswatini/ Swaziland
5
Zimbabwe
4
Zambia
4
Liberia
4
Tajikistan
3
Rwanda
3
Germany
3
Namibia
3
Botswana
3
North Macedonia
2
Thailand
2
Ukraine
2
Philippines
2
Guinea
2
Mozambique
2
Congo, Democratic Republic of
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Vietnam
2
Indonesia
2
Myanmar / Burma
2
Pakistan
2
Colombia
1
Australia
1
Benin
1
Gambia
1
Laos
1
Senegal
1
Burkina Faso
1
USA
1
Saudi Arabia
1
West and Central Africa
1
South–East Asia Region
1
North America
1
Uruguay
1
Maldives
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Brazil
1
Sri Lanka
1
Sudan
1
Mali
1
Libya
1
Bhutan
1
South Sudan
1
Iraq
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
186
Clinical Guidelines
72
Key Resources
62
Pharmacy & Technologies
23
Women & Child Health
19
Public Health
15
Capacity Building
10
Toolboxes
AMR
96
TB
84
Rapid Response
45
COVID-19
32
Planetary Health
21
HIV
19
Pharmacy
19
NTDs
19
Ebola & Marburg
13
Caregiver
13
Natural Hazards
8
Cholera
6
Refugee
5
Conflict
3
Zika
3
Global Health Education
3
Mental Health
2
Disability
2
Polio
2
Health Financing Toolbox
1
NCDs
1
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med...
Accessed Febr. 6, 2020
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
Topics in Antiviral Medicine 25 Issue 2 May/June 2017
Настоящие руководящие принципы предназначены для специалистов, имеющих дело с теми потребителями наркотиков, которые применяют наиболее проблемные модели потре...
We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retro...
A guide for practical implementation in adult and pediatric emergency department and urgent care settings
17th March 2020
HIV & AIDS Treatment in Practice No. 198
A key purpose of the Recovery Toolkit is to support countries in the reactivation of health services which may have suffered as a result of the emergency. These services include ongoing programmes such as immunization and vaccinations, maternal and child health services, and noncommunicable diseases...
The report summarizes the estimates of the burden of disease attributable to unsafe drinking water, sanitation, and hygiene for the year 2019 for four health outcomes - diarrhoea, acute respiratory infections, soil-transmitted helminthiases, and undernutrition - which are included in the reporting o...
